 Nes-Ziona, Israel, Sept. 29, 2021 GLOBE NEWSWIRE -- Enlivex Therapeutics Ltd. Nasdaq: ENLV, the Company, a clinical-stage macrophage reprogramming immunotherapy company, today announced that company management will participate in, and present at, the Reuters Events Cell Gene Therapy USA 2021 event, which is taking place virtually on September 28 and 29, 2021. 